Radio Sandwell Health News

One person brain-dead and five in hospital after drug testing 'accident'

2016-01-16 17:09:09

Biotrial Laboratory RennesBiotrial laboratory building in Rennes where a clinical trial took place Getty Images

One person has been left “brain-dead” and five more have been hospitalised after a clinical trial on an experimental drug went wrong in France.

The health ministry said the “serious accident” happened on Thursday, stopping the tests and forcing all volunteers to be recalled.

A statement released today did not confirm the name of the drug being tested but French media reports claimed it was a new cannabinoid-based painkiller.

Marisol Touraine, the French health minister, later said that the pill did not contain cannabis or its derivatives but acted on the body'sendocannabinoid system.

Taken orally, the drug was undergoing a Phase 1 clinical trial at a licensed private European laboratory that specialises in clinical trials, the French health ministry said.

The trial aimed to evaluate the “safety, tolerance and pharmaceutical properties of the molecule” in healthy volunteers.

“Marisol Touraine wants to express her solidarity and deep determination to get to the bottom of what happened and establish responsibility for this tragic accident,” a statement added.

One of the six volunteers is currently in intensive care at Rennes University Hospital, where the other five are also being treated.

France’s medicines agency (ANSM) has launched an investigation into the laboratory.

Share this story

Related Stories

Health news around the web

Autism diagnoses 'could be reduced under NHS plan'

Why Greek mountain villagers have healthy hearts

Charlie Gard's parents fight for Supreme Court hearing

Charlie Gard's parents lose life support court appeal

NHS cyber-attack: GPs and hospitals hit by ransomware

NHS in England hit by 'cyber-attack'

Sushi lovers warned of parasites danger in raw fish

Smartphone 'orders' body to treat diabetes

Cancer Drugs Fund 'huge waste of money'

Postpartum haemorrhage: Cheap lifesaver 'cuts deaths by a third'

Image Slider